![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 42, 40132-40141, October 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
**, and
From the Department of Molecular Medicine/Institute of
Biotechnology, University of Texas Health Science Center at San
Antonio, San Antonio, Texas 78245-3207, the ¶ Department of
Genetics and Development, Columbia University College of Physician
and Surgeons, New York, New York 10032-2704, and
BioCentrum-DTU,
Technical University of Denmark, 2800 Lyngby, Denmark
Received for publication, July 1, 2002, and in revised form, August 7, 2002
| |
ABSTRACT |
|---|
|
|
|---|
In the yeast Saccharomyces
cerevisiae, the RAD52 gene is indispensable for
homologous recombination and DNA repair. Rad52 protein binds DNA,
anneals complementary ssDNA strands, and self-associates to form
multimeric complexes. Moreover, Rad52 physically interacts with the
Rad51 recombinase and serves as a mediator in the Rad51-catalyzed DNA
strand exchange reaction. Here, we examine the functional significance
of the Rad51/Rad52 interaction. Through a series of deletions, we have
identified residues 409-420 of Rad52 as being indispensable and likely
sufficient for its interaction with Rad51. We have constructed a
four-amino acid deletion mutation within this region of Rad52 to ablate
its interaction with Rad51. We show that the rad52 Homologous recombination in eukaryotic organisms is conserved in
mechanism and mediated by a group of genes known as the
RAD52 epistasis group. The RAD52 group members
were first identified in the baker's yeast, Saccharomyces
cerevisiae, and include RAD50, RAD51, RAD52, RAD54, RAD55,
RAD57, RAD59, RDH54/TID1, MRE11, and XRS2
(1-4). In S. cerevisiae and in other
eukaryotes, homologous recombination is also an important
means of eliminating DNA double-stranded breaks induced by
ionizing radiation and other lesions that arise during the normal
course of DNA replication (4). In mammals, homologous recombination
also appears to be indispensable for cell viability and tumor
suppression (1, 4).
A DNA double strand break can be repaired by pathways that are based on
either end-joining or homologous recombination. In the latter case, the
ends of the break are processed by a nuclease to yield 3' ssDNA tails.
These ssDNA1 tails attract
recombination proteins, and the resulting nucleoprotein complex
conducts a search for a homologous DNA sequence. Next, one of the ssDNA
tails invades the homologous DNA target to form a DNA joint where
de novo DNA synthesis can take place, eventually leading to
an exchange of genetic information between the recombining chromosomes
and to restoration of the integrity of the broken chromosome (2,
3).
The enzymatic process responsible for the formation of heteroduplex DNA
joints in recombination is called homologous DNA pairing and strand
exchange (2). The RAD51 encoded product, the equivalent of
the Escherichia coli recombinase RecA, mediates the
homologous DNA pairing and strand exchange reaction (5). Electron
microscopic analyses have indicated that Rad51, like E. coli
RecA protein, forms a highly ordered nucleoprotein filament on DNA (6).
Biochemical studies have suggested that pairing and exchange of DNA
strands in recombination processes occur within the confines of the
Rad51-ssDNA nucleoprotein filament. The reaction phase in which the
Rad51-ssDNA nucleoprotein filament is assembled is commonly referred to
as the presynaptic phase, and the nucleoprotein filament as the
presynaptic filament (2, 6, 7).
Formation of the presynaptic filament requires ATP binding by Rad51
(2). When plasmid length ssDNA substrates are used, presynaptic
filament assembly is facilitated by the heterotrimeric single-stranded DNA binding factor, replication protein A (RPA), which
functions to remove secondary structure in the ssDNA (5, 8, 9). The
beneficial effect of RPA is seen most clearly when it is incorporated
after Rad51 has been given an opportunity to nucleate onto the ssDNA
template. In contrast, if RPA is added together with Rad51, it
interferes with the filament assembly process by competing for binding
sites on the ssDNA molecule. However, the inhibitory behavior of RPA
can be alleviated by the addition of either of two recombination
mediators (10), Rad52 or the Rad55-Rad57 heterodimer (11-14).
We are interested in the molecular basis of the mediator function of
Rad52 and the Rad55-Rad57 heterodimer in the above mentioned reaction.
Both Rad52 and the Rad55-Rad57 complex bind ssDNA and physically
interact with Rad51 (15).2 In
the present study, we have performed a fine mapping of the domain in
Rad52 that is responsible for the interaction with Rad51. Furthermore,
we have used this information to introduce a small deletion mutation
into Rad52 to ascertain the significance of Rad51-interaction in Rad52
mediator function. The combination of genetic and biochemical analyses
of the mutant rad52 protein unequivocally demonstrate the requirement
for a physical association of Rad52 with Rad51 to effect its mediator function.
Yeast Media and Strains--
Yeast extract-peptone-dextrose
(YPD) medium, synthetic complete (SC) medium, and synthetic complete
medium without leucine (SC Plasmids for Protein Expression--
GST fusion fragments of
Rad52 were constructed as follows: GST-Rad52N (aa 1-168), GST-Rad52 M
(aa 169-327), and GST-Rad52C (aa 328-504), encoded within the
HpaII/BglII, BglII/BamHI,
and BamHI/DraI fragments from the
RAD52 open reading frame were subcloned into
SmaI-digested pGEX-3X, BamHI-digested pGEX-2T,
and SmaI-digested pGEX-3X vector, respectively. For the
expression of other GST fusion proteins, specific primers with
EcoRI sites were used for the PCR reactions. The PCR
products were digested with EcoRI, purified by phenol
extraction and ethanol precipitation, and then ligated into
EcoRI-linearized pGEX-3X vector to fuse the Rad52 fragments
to the GST protein. The ligation products were transformed into
E. coli strain BL21(DE3) for protein expression.
DNA Substrates--
The DNA Binding Assays--
Varying amounts of Rad52 or rad52
Single-stranded DNA Annealing Assays--
Oligo-1 (3.6 µM nucleotides) and radiolabeled Oligo-2 (3.6 µM nucleotides) were incubated in separate tubes at
37 °C for 2 min in the absence or presence of RPA (0.55 µM) in
24 µl of buffer D. Rad52 or rad52 Purification of Proteins--
All of the GST fusion proteins
were expressed in E. coli strain BL21(DE3), and all of the
protein purification steps were carried out at 4 °C. For the
purification of the GST fusion proteins, lysate was prepared from
E. coli cell paste using a French press in buffer G (20 mM NaH2PO4, pH 7.4, 0.5 mM EDTA, 1 mM DTT, and 150 mM NaCl
that also contained the protease inhibitors aprotinin, chymostatin,
leupeptin, and pepstatin A at 5 µg/ml each, as well as 1 mM phenylmethylsulfonyl fluoride). The crude lysate was
clarified by centrifugation (100,000 ×g, 90 min), and the
supernatant (20 ml) from the centrifugation step was mixed with 1 ml of
glutathione-Sepharose 4B (Amersham Biosciences) for 3 h at
4 °C. The beads were washed three times with 20 ml of buffer G
containing 150 mM KCl. The bound GST fusion protein was
eluted with 5 ml of 10 mM reduced glutathione in buffer G. The eluate was dialyzed against buffer G and concentrated to 10 mg/ml
in a Centricon-30 microconcentrator.
Plasmids encoding untagged versions of Rad52 protein (pR52.2) and
rad52 GST Pull-down Assay--
The purified GST fusion proteins (0.4 µM) were incubated with purified Rad51 (0.2 µM) in 30 µl buffer G and incubated at 4 °C for
1 h before the reaction mixture was mixed with 10 µl of glutathione-Sepharose-4B beads in 150 µl of buffer K (20 mM KH2PO4, pH 7.4, 150 mM KCl, 10% glycerol, 0.01% Nonidet P-40) at 4 °C for
an additional hour. The beads were then washed twice with 150 µl of
buffer K with 300 mM KCl, and the bound proteins were eluted with 30 µl of 3% SDS. The supernatant that contained unbound protein, the KCl wash (10 µl each), and also the SDS eluate (3 µl)
were subjected to immunoblotting analysis with anti-Rad51 antibodies to
determine their Rad51 content. Coomassie Blue staining of the SDS
eluates revealed that ~70% of GST and all of the GST fusion proteins
were immobilized on glutathione-Sepharose.
Binding of Rad52 to Rad51 Immobilized on Affi-gels--
Affi-gel
15 beads containing Rad51 (Affi-Rad51; 5 mg/ml) and bovine serum
albumin (Affi-BSA, 12 mg/ml) were prepared as described previously
(24). Purified Rad52 or rad52 Gel Filtration--
A Sephacryl S400 column (1 × 30 cm, 20 ml total) was used to monitor the migration of Rad51 (30 µg), Rad52
(40 µg) and rad52 DNA Strand Exchange Reactions--
All steps were carried out at
37 °C unless stated otherwise. The standard DNA strand exchange
reaction was performed as described previously (23). Briefly, Rad51 (10 µM) was incubated with ssDNA (30 µM
nucleotides) in 10 µl of buffer R (35 mM K-MOPS,
pH 7.2, 1 mM DTT, 50 mM KCl, 2.5 mM
ATP, and 3 mM MgCl2) for 5 min. After the
addition of the indicated amounts of RPA in 0.5 µl, the reaction mixtures were incubated for another 5 min before the incorporation of 1 µl of double-stranded DNA (25 µM nucleotides)
and 1 µl of 50 mM spermidine hydrochloride. At the
indicated times, a 4.5-µl portion of the reaction mixtures was
withdrawn, deproteinized, and then analyzed in 0.9% agarose gels in
TAE buffer. The gels were treated with eithidium bromide to stain the
DNA species. Gel images were recorded in a NucleoTech gel documentation
system and analyzed with GelExpert software. To examine the Rad52
mediator function, reaction mixtures (12.5 µl, final volume)
containing the indicated amounts of Rad51, Rad52, and RPA were
incubated on ice for 45 min in 10.5 µl of buffer R followed by the
addition of ssDNA and a 10-min incubation. After the incorporation of
linear duplex and spermidine, the completed reactions were incubated and analyzed as described for the standard reaction. For the time course experiments in Fig. 7, the reactions were scaled up four times
to 50 µl but were otherwise assembled in the same fashion.
Cellular Sensitivity to Determination of Mitotic Recombination Rates, Sporulation
Efficiency, and Meiotic Recombination Frequencies--
Mitotic rates
of interchromosomal heteroallelic recombination were determined as
described previously (26). For each strain, nine independent trials
were performed. The meiotic interchromosomal heteroallelic
recombination frequency, sporulation efficiency, and spore viability
were determined as described in Lisby et al. (27) except
that strains were grown at 30 °C. Three trials were performed for
each strain.
Location of the Rad51 Interaction Domain--
Rad52 possesses 504 amino acid residues (28). Results from yeast two-hybrid analyses have
suggested that the carboxyl terminus of Rad52 encompassing residues 328 to 504 can interact with Rad51 (29). Exploiting this information, we
divided Rad52 into three fragments: Rad52N (aa 34-168), Rad52 M (aa
169-327), and Rad52C (aa 328-504), which were fused individually to
glutathione-S-transferase (GST) as depicted in Fig.
1A. These GST fusion proteins
were expressed in E. coli and purified using affinity
chromatography on glutathione-Sepharose (Fig. 1B). We also
expressed and purified a GST fusion protein, termed GST-NMC, which
contain the Rad52 protein sequence starting from the third ATG codon
(aa 34); the region corresponding to amino acid 1-34 is not required
for in vivo Rad52
function.3 To determine which
portion of Rad52 contains the Rad51 binding domain, the purified GST
fusion proteins were mixed with Rad51 and then immobilized on the
glutathione-Sepharose beads. After washing with high salt buffer, the
GST fusion proteins and associated Rad51 were eluted from the
glutathione beads by treatment with SDS and then analyzed by
immunoblotting with anti-Rad51 antibodies (Fig. 1C). The
results show that Rad51 binds GST-NMC and GST-C, but not GST-N, GST-M,
or GST alone. We then asked whether the purified GST fusions could be
retained on Affi-gel 15 beads that contained covalently coupled Rad51
protein (24). As expected, the Affi-Rad51 beads were able to bind
GST-NMC and GST-C but not GST-M, GST-N, or GST (data not shown). None
of the GST-Rad52 fusion proteins was retained on Affi-gel 15 beads
containing bovine serum albumin (data not shown). Thus, in agreement
with yeast two-hybrid studies (29), the results from our in
vitro analyses with purified Rad52 protein fragments revealed that
the Rad51 interaction domain is located within the last 177 amino acid
residues of Rad52 protein.
Fine Mapping of Rad51 Interaction Domain and Construction of a
Rad51 Interaction-defective Mutant--
To delimit the region in Rad52
required for interaction with Rad51, additional GST-tagged fragments of
Rad52 derived from the carboxyl-terminal residues were generated (Fig
2A). These GST fusions were
again purified by affinity chromatography and tested for Rad51
interaction by pull-down using glutathione-Sepharose beads as described
before (Fig. 1C). The binding of the various GST-Rad52
fusions to Affi-gel-Rad51 beads was also examined. The results from
these combined analyses, as summarized in Fig. 2, revealed that amino
acids 407-419 of the Rad52 protein are likely involved in binding
Rad51.
Overexpression of the Rad52 protein from another yeast, K. lactis, confers a dominant negative phenotype in S. cerevisiae that can be overcome by overexpression of the S. cerevisiae Rad51 (29). The authors of this study (29) suggested
that the negative dominance of the K. lactis Rad52 in
S. cerevisiae cells is due to the formation of a
biologically inactive complex between KlRad52 and ScRad51. Even though
the carboxyl terminus of the S. cerevisiae and K. lactis Rad52 counterparts display only a low level of identity (29%), the KlRad52 protein contains a sequence that is highly similar
to the one in ScRad52 protein found here to be involved in Rad51
binding (Fig 2B). Consistent with the suggestion that the
sequence encoded within amino acid residues 407-419 of Rad52 is
critical for Rad51 binding, we found that a small deletion spanning
amino acid residues 409-412 within this region completely ablates the
ability of Rad52 to interact with Rad51 (Fig. 2A, panel II), as determined by the GST pull-down assay, binding
of the GST fusion proteins to Affi-Rad51 beads, and other criteria (see below).
Purification and Biochemical Characterization of a Rad51
Interaction-deficient Rad52 Mutant--
The results presented above
show that amino acid residues 409-412 are likely to be required for
Rad51 binding. To further demonstrate the importance of these four
amino acid residues, we introduced the same deletion mutation
(
Unlike wild-type Rad52 protein, the purified rad52
As first reported by Mortensen et al. (15) and later
confirmed by others (13, 14, 23), Rad52 possesses an ssDNA binding function. We therefore addressed the possibility that the four-amino acid deletion affects the DNA binding activity of the rad52
In addition to DNA binding, Rad52 also anneals complementary DNA
strands (15). Interestingly, the Rad52-mediated DNA annealing reaction
occurs efficiently with RPA-coated DNA strands (8, 14), whereas RPA
alone slows the spontaneous rate of DNA annealing (8, 14). This
annealing reaction is likely to involve a specific interaction between
Rad52 and RPA, as the heterologous E. coli SSB and human RPA
strongly inhibit the Rad52-ssDNA annealing activity (8). We examined
the rad52
Taken together, the biochemical analyses documented here allowed us to
conclude that rad52 rad52
We and others have shown that, with plasmid length DNA substrates, the
efficiency of the Rad51-mediated DNA strand exchange reaction is
greatly enhanced by RPA (8, 12). However, the order of addition of RPA
relative to Rad51 is critical for efficient DNA strand exchange.
Specifically, if RPA is added after Rad51 has already nucleated onto
the ssDNA, a robust strand exchange reaction is observed. In contrast,
if RPA is added to the ssDNA at the same time as Rad51, the level of
DNA strand exchange diminishes greatly (11-14) (Fig.
6B, panels I and
II). As shown before and repeated here (Fig. 6B,
panel III), the inhibitory effect of RPA in the latter
experiment can be alleviated by adding a substoichiometric amount of
Rad52 (10 µM Rad51 and 1.2 µM Rad52). In
contrast, when the same experiment was performed with the equivalent
amount of rad52 Repair and Recombination Defects of rad52
We also compared the frequencies of meiotic interchromosomal
heteroallelic recombination and spore viability of wild-type RAD52 and rad52 The Rad51 interaction domain was first shown to reside within the
carboxyl-terminal 177 amino acids residues of Rad52 by a yeast
two-hybrid analysis (29). Here we have verified the two-hybrid result
by showing biochemically that the carboxyl terminus, but not the
amino-terminal and middle portions, of Rad52 has the ability to bind
Rad51 in the absence of another protein factor or DNA. Next, we finely
mapped the Rad51 interaction domain and used this information to
conduct a variety of biochemical and genetic experiments to firmly
establish the biological and functional significance of the Rad51-Rad52 association.
First we examined a series of deletion fragments derived from the
carboxyl terminus of Rad52 for complex formation with Rad51. The
results strongly suggest that a short sequence encompassing residues
407-419 is involved in mediating interaction with Rad51. This mapping
information and a sequence comparison to K. lactis Rad52
prompted us to introduce a short deletion in the region spanning
residues 409-412 into the full-length Rad52 protein. We find that the
rad52 In DNA strand exchange experiments, the rad52 The DNA repair deficiency of the rad52 The rad52 null mutation renders cells highly defective in
recombination, and overexpression of Rad51 does not compensate for the
loss of Rad52 (36). Thus, Rad52 must have a function in recombination/repair pathways independent of Rad51 interaction. It is
possible that in the cellular setting, Rad52 renders the RPA-coated
ssDNA template more accessible to Rad51 even in the absence of a
specific interaction with Rad51. Alternatively, or additionally, the
Rad51 interaction-defective rad52 variant may enhance the
interaction between Rad51 and other recombination mediators without
directly contacting Rad51. Also, it seems possible that the severe
phenotype associated with RAD52 deletion may be related to
the ability of Rad52 to promote the assembly of DNA repair centers as
revealed in recent cytological studies (27).
409-412 mutant
protein is defective in the mediator function in vitro even
though none of the other Rad52 activities, namely, DNA binding, ssDNA
annealing, and protein oligomerization, are affected. We also show that
the sensitivity of the rad52
409-412 mutant to ionizing
radiation can be complemented by overexpression of Rad51. These results
thus demonstrate the significance of the Rad51-Rad52 interaction in
homologous recombination.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Leu) and without uracil (SC
Ura) were
prepared as described previously (16) except that the synthetic media
contained twice the amount of leucine (60 mg/liter). Yeast
extract-peptone-acetate (YEPA) contained 10 g/liter yeast extract, 20 g/liter peptone, and 20 g/liter potassium acetate. Sporulation medium
contained 2.5 g/liter yeast extract and 15 g/liter potassium acetate
supplemented with 62 mg/liter Leu and 20.6 mg/liter each of adenine,
His, Trp, and uracil. All strains are derivatives of Trp-303
(17) except that they are wild type for RAD5 (18, 19).
Standard genetic techniques were used to manipulate yeast strains (20).
The rad52
409-412 allele was integrated into the yeast
genome at the RAD52 locus by a cloning-free PCR-based allele
replacement method (21). Specifically, gene-targeting substrates were
made by amplifying a region of the rad52 allele,
which comprises the
409-412 mutation, from the vector
pR52
409-412.1 by PCR using the primers and Pr-Rad52-C-Adap-B (5'-GATCCCCGGGAATTGCCATGTGGTCTTCCAACTTCTCTTCG-3')
and Pr-C-adap-A (5'-AATTCCAGCTGACCACCATGAAGGATCCCGTTGTAGCTAAG-3'). The
underlined sections of the primers correspond to unique tags that match
sequences upstream and downstream of Kluyveromyces lactis
URA3, respectively. Next, two PCR fragments containing the
upstream and the downstream two-thirds of the K. lactis URA3
gene were fused individually to the rad52
409-412 PCR
fragment as described in Erdeniz et al. (21).
X 174 viral (+) strand was purchased
from New England Biolabs, and the replicative form (about 90%
supercoiled form and 10% nicked circular form) was from
Invitrogen. Oligonucleotide 1 used in the ssDNA annealing and
DNA binding experiments had the sequence
5'-AAATGAACATAAAGTAAATAAGTATAAGGATAATACAAAATAAGTAAATGAATAAACATAGAAAATAAAGTAAAGGATATAAA-3'. Oligonucleotide 2 is the exact complement of oligonucleotide 1. These
oligonucleotides were purified from a 15% polyacrylamide gel as
described previously (22). The two oligonucleotides were labeled with
[
-32P]ATP and T4 polynucleotide kinase for use in DNA
binding and single strand annealing experiments.
409-412 protein was incubated with 32P-labeled Oligo-1
(1.36 µM nucleotides) at 37 °C in 10 µl of buffer D
(40 mM Tris-HCl, pH 7.8, 50 mM KCl, 1 mM DTT, and 100 µg/ml bovine serum albumin) for 10 min.
After the addition of gel loading buffer (50% glycerol, 20 mM Tris-HCl, pH 7.4, 2 mM EDTA, 0.05% orange
G), the reaction mixtures were resolved in 12% native polyacrylamide gels at 4 °C in TAE buffer (40 mM Tris-HCl, pH 7.4, 0.5 mM EDTA) and dried, and the DNA species were quantified
using Quantity One software in the phosphorimaging device
(Personal Molecular Imager FX from Bio-Rad). To release the bound DNA,
the reaction mixture was deproteinized with 0.5% SDS and 500 µg/ml
proteinase K at 37 °C for 10 min before being loading onto the
polyacrylamide gel.
409-412 (0.36 µM)
was added in 2 µl to the tube containing Oligo-1 and then mixed with
Oligo-2. The completed reactions (50 µl) were incubated at 25 °C,
and at the indicated times, 9 µl of the annealing reactions was
removed and treated with 0.5% SDS, 500 µg/ml proteinase K, and an
excess of unlabeled Oligo-2 (20 µM) at 25 °C for 5 min
in a total volume of 15 µl. The various samples (6 µl) were
resolved in 12% native polyacrylamide gels run in TAE buffer. DNA
annealing was quantified as the portion of the 32P-labeled
Oligo-2 that had been converted into the double-stranded form.
409-412 mutant protein (pR52
409-412.1) under the control
of the GAL-PGK promoter were introduced into yeast strain BJ5464-6B. For the purification of these proteins, extract was prepared
from 300 g of cell paste from 100 liters of culture in high salt
buffer (23). The extract was clarified by centrifugation and then
subjected to the chromatographic fractionation procedure described
before (12) except that Sephacryl 400 was used instead of Sepharose 6B
in the gel filtration step.
409-412 (5 µg) was mixed with 5 µl of Affi-Rad51 or Affi-BSA in 50 µl of buffer K for 30 min at
4 °C. The beads were washed once with 150 µl of buffer K before
being treated with 50 µl of 2% SDS to elute-bound proteins. The
starting material, supernatant that contained unbound Rad52 or rad52
protein, and the SDS eluate (10 µl each) were analyzed by SDS-PAGE in
a 10% gel.
409-412 (40 µg) and to examine complex
formation between Rad51 (30 µg) and Rad52 (40 µg). The mixtures of
Rad51/Rad52 and Rad51/rad52
409-412 were incubated on ice for 1 h in 100 µl of buffer K and then filtered through the sizing column
at 0.1 ml/min in the same buffer, collecting 0.5 ml fractions. The
indicated column fractions were separated by SDS-PAGE electrophoresis
to determine their content of the Rad51, Rad52, or rad52
409-412
proteins, respectively. For calibration of the column, thyroglobulin
(669 kDa), catalase (232 kDa), and dextran blue (>2000 kDa) were used.
-Irradiation--
Three independent
haploid spores from each strain were picked and analyzed for their
sensitivity to
-irradiation, and the average values were reported.
Yeast cultures were grown in YPD at 30 °C to the mid-log phase. At
this point, the cultures were sonicated using a W-385 device (Heat
Systems-Ultrasonics, Farmingdale, NY), and the appropriate number of
cells were plated on YPD plates and irradiated in a Gammacell-220
60Co irradiator (Atomic Energy of Canada). In Fig.
8B, cells transformed with pYESS10-Rad51 (2µ,
RAD51) and with the empty vector pRS426 (25) were grown on
selective medium (SC
Ura) containing galactose as the sole
carbon source at all stages of the experiment. The yeast cultures were
analyzed as described above, except that for each strain, serial
10-fold dilutions were made and 5 µl of the diluted cell suspensions
were spotted in duplicate on solid media prior to irradiation.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (13K):
[in a new window]
Fig. 1.
The carboxyl terminus of Rad52 is responsible
for interaction with Rad51. A, schematic representation
of GST fusion proteins consisting of near full-length Rad52
(NMC) as well as the amino-terminal (GST-N), the
middle (GST-M), and the carboxyl-terminal (GST-C)
portions of Rad52. B, purified GST, GST-NMC, GST-M, and
GST-C, 1 µg each and designated by an asterisk, were run
in a 10% denaturing polyacrylamide gel and stained with Coomassie
Blue. C, GST pull-down assay. Purified GST fusion
proteins were incubated individually with Rad51 and then mixed with
glutathione-Sepharose beads. The beads were washed twice with buffer
containing 300 mM KCl before being treated with SDS to
elute bound proteins. The input material (I), the
supernatant after mixing with glutathione-Sepharose (S), the
KCl wash (W), and the SDS eluate (E) from these
binding reactions were subjected to electrophoresis in a 10%
denaturing polyacrylamide gel followed by immunoblot analysis with
anti-Rad51 antibodies to determine their Rad51 content.

View larger version (22K):
[in a new window]
Fig. 2.
Minimal region required for Rad51-Rad52
association. A, panel I, summary of domain
mapping results from pull-down experiments with GST fusion proteins
containing different segments of the Rad52 carboxyl terminus, done as
described for Fig. 1C. The numbers indicate the
amino acid residues in Rad52 protein. The ability (Y) or
inability (N) of individual Rad52 fragments to bind Rad51 is
indicated. The region (residues 407-419) common to all of the Rad52
fragments capable of Rad51 binding is shown in black.
Panel II shows the two GST-Rad52 fusion proteins deleted for
four amino acids (YEKF) in the putative Rad51 binding
domain. This deletion mutation (
409-412) ablates the ability to
bind Rad51. Panel III shows the GST pull-down assay with
three Rad52 carboxyl-terminal fragments. Purified GST-(378-419),
GST-(407-504), and GST-(328-504), with deletion of residues 409-412,
were mixed with glutathione-Sepharose beads. The input mixture
(I), the unbound protein in the supernatant (S),
the wash (W), and the SDS eluate (E) were
analyzed by SDS-PAGE. The amount of Rad51 protein was determined by
immunoblot analysis. B, comparison of S. cerevisiae and K. lactis Rad52 sequences that contain
the likely Rad51 binding domain. The four amino acids deleted in
the ScRad52 protein are in boldface type.
409-412) into the untagged Rad52 protein. For biochemical
analyses, we overexpressed both the rad52
409-412 mutant and the
wild-type protein by using the GAL-PGK promoter and
galactose induction in the protease-deficient yeast strain BJ5464-6B.
The level of expression of the wild-type and mutant proteins was very
similar (data not shown), and they could be purified to near
homogeneity by the same chromatographic procedure (see "Materials and
Methods"; Fig. 3A).
Approximately 1 mg of each of the wild-type and mutant proteins was
obtained from 300 g of starting yeast paste. This represents a
5-10-fold improvement compared with protein yield obtained when the
PGK promoter is used for protein expression, as described in
our previously published study (12).

View larger version (6K):
[in a new window]
Fig. 3.
Mutation in Rad52 that abrogates interaction
with Rad51. A, SDS-PAGE analysis of Rad52 (2 µg,
lane 1) and rad52
409-412 (2 µg, lane 2)
proteins. B, purified wild type and rad52
409-412
were mixed with Affi-Rad51 beads. The beads were washed with buffer and
then treated with SDS to elute bound Rad52 and rad52
409-412. The
input mixture (I), the supernatant containing unbound Rad52
or rad52
409-412 (S), the wash (W), and the
SDS eluate (E) were run on 10% SDS-PAGE followed by
staining with Coomassie Blue. Given the oligomeric nature of Rad51 (23,
30), some of the Rad51 molecules were tethered to the Affi-beads
through other covalently conjugated molecules and therefore were
readily eluted by SDS treatment (lanes 4 and 8).
The rad52
409-412 mutant protein is designated as
rad52.
409-412 mutant
protein did not bind Affi-Rad51 beads (Fig. 3B), indicating that the four-amino acid deletion indeed eliminates the ability of
Rad52 to associate with Rad51. Both Rad51 and Rad52 self-associate to
form oligomeric molecules (14, 23, 30). A very large complex of these
two proteins can be isolated in a sizing column (23). Accordingly, we
subjected the purified rad52
409-412 mutant protein to sizing
analysis in Sephacryl 400 to obtain independent verification that it
does not associate with Rad51 and also to determine whether the
409-412 mutation affects self-association. When a mixture of Rad51
and wild-type Rad52 was analyzed, they formed a complex that emerged
from the gel filtration column at an earlier position than either Rad51
or Rad52 alone (Fig. 4, compare
panel IV with panels I and III). In
contrast, when the rad52
409-412 mutant was mixed with Rad51, no
apparent shift of the elution profile of either protein was observed
(Fig. 4, compare panel V with panels II and
III). Importantly, the peak of the rad52
409-412 mutant
protein migrated at the same position as wild-type Rad52 (Fig. 4,
compare panels I and II), strongly suggesting that the mutant rad52 protein has the same oligomeric composition as
the wild-type protein. Thus, the results from the gel filtration analyses demonstrated that the rad52
409-412 mutant is defective in
Rad51 interaction but maintains the ability to self-associate.

View larger version (46K):
[in a new window]
Fig. 4.
Oligomeric structure of Rad52 is unaffected
by the
409-412 mutation. Rad52 protein
(panel I), rad52
409-412 protein (panel II),
and Rad51 protein (panel III) were filtered through a
Sephacryl S400 column. In panels IV and V, Rad51
and either Rad52 (IV) or rad52
409-412 (V)
were mixed, incubated on ice for 1 h, and then filtered. The
indicated fractions were run on 10% SDS-PAGE followed by staining with
Coomassie Blue. The elution positions of the size markers are
indicated: DB, dextran blue (>2,000 kDa); TG,
thyroglobulin (669 kDa); CAT, catalase (223 kDa).
409-412 mutant protein. To do this, increasing amounts of Rad52 and
rad52
409-412 proteins were incubated with a 32P-labeled
83-mer oligonucleotide. Subsequently, the capacity of these proteins to
bind DNA was evaluated by gel mobility shift of the radiolabeled DNA
substrate. The results presented in Fig. 5A show that rad52
409-412
shifts the DNA fragment just as efficiently as the wild-type protein.
We also used
X ssDNA as substrate to test the DNA binding capacity
of the protein species. As in the previous experiment, no difference in
DNA binding activity was observed between wild-type and mutant proteins
(data not shown).

View larger version (28K):
[in a new window]
Fig. 5.
DNA binding and strand annealing activities
of rad52
409-412. A, in
panel I, 32P-labeled Oligo-1 (1.4 µM nucleotides), designated as ss, was
incubated without protein (Bl; lane 1) and with
Rad52 (35, 70, 105, and 140 nM in lanes 2-5,
respectively) or rad52
409-412 (35, 70, 105, and 140 nM
in lanes 6-9, respectively). The reaction mixtures were
analyzed on a nondenaturing polyacrylamide gel, which was dried and
subjected to phosphorimaging analysis to quantify the results
(panel II). The rad52
409-412 mutant is designated as
rad52. B, unlabeled Oligo-1 (3.6 µM nucleotides) and radiolabeled Oligo-2 (3.6 µM nucleotides) were incubated separately with RPA (0.55 µM; panels I, II, and
III) for 2 min. The annealing reactions were initiated by
mixing the RPA-coated oligonucleotides and Rad52 (0.36 µM; panel II) or rad52
409-412 (0.3 µM; panel III) in a final volume of 50 µl.
At the indicated times, 9 µl of each reaction was removed and treated
with 0.5% SDS, 500 µg/ml proteinase K, and an excess of unlabeled
Oligo-2 (20 µM nucleotides) at room temperature for 5 min. The reaction mixtures were resolved in 12% native polyacrylamide
gels. Panel I displays results from the reaction in which no
Rad52 or rad52
409-412 was added. C, in
panel I, the results from B are graphed. Another
set of strand annealing experiments using the same amounts of RPA-free
DNA substrates and Rad52 or rad52
409-412 were carried out as in
B, and the results are graphed in panel II.
Consistent with previously published work (8), a higher spontaneous
rate of DNA annealing was seen in the absence of RPA (compare the RPA
curve in panel I with the no protein curve in panel
II).
409-412 mutant protein for its ability to anneal
ScRPA-coated complementary single strands. The results from this
experiment indicate that the rate and extent of the annealing reaction
obtained in the presence of either Rad52 or rad52
409-412 are
essentially identical for both (Fig. 5B and Fig.
5C, panel I). With DNA substrates free of ScRPA,
the rad52
409-412 mutant protein was again as proficient as
wild-type Rad52 in its annealing reaction (Fig. 5C,
panel II). This observation shows that rad52
409-412
likely retains the ability to physically interact with RPA.
409-412 mutant has the wild-type level of ssDNA
binding and DNA annealing activities and also possesses the same
oligomeric state as the wild-type protein. In addition, the ability of
the rad52
409-412 mutant to anneal RPA-coated single strands like
the wild-type protein is consistent with the premise that it retains
the ability to interact with RPA.
409-412 Mutant Is Specifically Defective in Mediator
Function--
The above data have demonstrated that the
rad52
409-412 mutant protein does not interact with Rad51 but that
it otherwise behaves like the wild-type protein in various biochemical
attributes. We next tested whether the rad52
409-412 mutant protein
retains the recombination mediator activity of wild-type Rad52.
409-412 mutant protein, the suppressed level of DNA
strand exchange caused by RPA was not relieved. In fact, the presence of the rad52
409-412 protein further reduced the already low level of DNA strand exchange caused by RPA co-addition. Because of this result, we also examined lower amounts of rad52
409-412 (0.4 to 1.0 µM) for a possible mediator effect but found that it is
devoid of such activity at any of these concentrations (Fig.
7, lanes 8-12). On the other
hand, the addition of rad52
409-412 (0.4-1.2 µM) and
RPA to a preformed Rad51-ssDNA complex did not affect the efficiency of
DNA strand exchange (data not shown). Taken together, the results
establish a direct linkage between the Rad51-interacting activity of
Rad52 and its mediator function in the DNA strand exchange
reaction.

View larger version (55K):
[in a new window]
Fig. 6.
The rad52
409-412
mutant lacks recombination mediator activity. A,
schematic representation of the homologous DNA pairing and strand
exchange reaction. Homologous pairing between the ssDNA (ss)
and linear duplex (ds) substrates yields a DNA joint
molecule (jm), which is converted into a nicked circular
duplex molecule (nc) by strand exchange. B,
in panel I, the
X174 ssDNA (30 µM
nucleotides) was first incubated with Rad51 (10 µM) for 5 min before RPA (2 µM) was added. Following another 5-min
incubation, the linear duplex (25 µM nucleotides) was
incorporated to complete the reaction. The reaction in panel
II contained the same amount of DNA substrates and proteins as
panel I except that the ssDNA was incubated with both Rad51
and RPA for 10 min before the duplex was added. The reactions in
panels III and IV were assembled as in
panel II except that either Rad52 (1.2 µM) or
rad52
409-412 (1.2 µM; designated as rad52) was also
present during the incubation of ssDNA with Rad51 and RPA.
C, graphical representation of the results in
B.

View larger version (56K):
[in a new window]
Fig. 7.
Mediator activity as a function of
concentration of Rad52 or rad52
409-412.
A, increasing amounts of either Rad52 (0.4, 0.6, 0.8, 1.0, and 1.2 µM in lanes 3-6, respectively)
or rad52
409-412 (0.4, 0.6, 0.8, 1.0, and 1.2 µM in
lanes 8-12, respectively), Rad51 (10 µM;
lanes 2-12), or RPA (2 µM; lanes
2-12) were incubated with ssDNA (30 µM nucleotides)
for 10 min followed by the incorporation of the linear duplex (25 µM nucleotides) to complete the reactions; the reaction
in lane 2 (Inh) did not contain Rad52 or
rad52
409-412. In lane 1 (Std), ssDNA (30 µM) was incubated with Rad51 (10 µM) for 5 min followed by the addition of RPA (2 µM) and a 5-min
incubation before the duplex substrate (25 µM
nucleotides) was incorporated to complete the reaction. Aliquots of the
reactions were withdrawn at 30 and 60 min and processed for
electrophoresis. The results from the 30-min time point are shown.
B, the results from A and from analyzing the
gel containing the 60-min time point samples are graphed.
409-412--
The
biochemical experiments described above demonstrated a specific defect
in the rad52
409-412 mutant protein, namely, that it fails to
interact with Rad51 and is devoid of recombination mediator function.
To establish the role of the Rad52 mediator activity in
vivo, we replaced the chromosomal RAD52 gene with the
rad52
409-412 allele in the Trp-303 background (see
"Material and Methods") and then tested the mutant strain for its
-ray sensitivity. The rad52
409-412 mutant strains
show a marked increase in sensitivity to ionizing radiation although
not to the same extent as isogenic rad52 deletion strain
(Fig. 8A). This result indicates that the interaction with Rad51 is indeed important for the
full biological activity of Rad52 protein in double strand break
repair in vivo. Interestingly, the
-ray sensitivity of the rad52
409-412 mutant can be complemented fully by the
overexpression of the Rad51 protein on a 2µ plasmid (Fig.
8B). Similar complementation by Rad51 overexpression has
been observed by Livingston and Kaytor (31) for a
rad52 allele (rad52
327) that lacks the
carboxyl-terminal 177 residues.

View larger version (33K):
[in a new window]
Fig. 8.
-Ray sensitivity of the
rad52
409-412 mutant. A, the log
fraction of surviving cells (% survival) after exposure to
the indicated doses of
-radiation (krad) of yeast strains
with the following genetic backgrounds: wild-type RAD52
(wt), rad52
409-412 (rad52), and
rad52
(null). B, effect of
RAD51 overexpression. RAD52 or
rad52
409-412 cells were spotted in serial 10-fold
dilutions and irradiated as indicated (0, 20, 40, and 80 kilorads). The same set of strains was also transformed with a
2µ vector or the same vector containing the
RAD51 gene and then analyzed. The
rad52
409-412 allele is designated
rad52.
409-412 strains (data not
shown). In both cases, no significant differences were observed,
indicating that the Rad51-Rad52 interaction is not essential for
successful completion of meiosis. In contrast, the mitotic
interchromosomal heteroallelic recombination is reduced 4-fold in the
rad52
409-412 strain (data not shown). Thus, the overall
phenotype of the rad52
409-412 strain is very similar to
that obtained with the rad52
327 strain except that the
spore viability of the latter strain is somewhat impaired (32).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
409-412 mutant protein can be stably expressed in yeast cells
and that it behaves like wild-type Rad52 during column chromatography,
allowing us to use the same procedure to purify both wild-type and
mutant proteins to near homogeneity for biochemical experiments. Here
we have shown, by several criteria, that the rad52
409-412 mutant
protein lacks the ability to interact with Rad51. In contrast, its
ability to bind DNA and mediate DNA annealing, as well as its
oligomerizing properties, are indistinguishable from those of the
wild-type protein. These results demonstrated that the short sequence
(i.e. aa residues 407-419) in Rad52 identified in our
mapping work is likely to be indispensable to and is possibly responsible for Rad51 binding. Furthermore, the biochemical results have verified that the Rad51 interaction-defective rad52
409-412 mutant is normal in all other known biochemical attributes of Rad52.
409-412 mutant protein
over a wide range of concentrations is devoid of the mediator function
seen in the Rad52 protein. Consistent with the biochemical result, the
rad52
409-412 mutation renders cells sensitive to
ionizing radiation and confers a 4-fold decrease in mitotic recombination. It has been suggested from yeast two-hybrid and in
vitro studies that Rad52 physically interacts with RPA and that
this interaction is important for its mediator activity and biological
function (8, 13, 14, 33). It could be argued that the lack of mediator
function in the rad52
409-412 mutant protein is due to an inability
to recognize RPA. We have attempted to demonstrate a direct interaction
between purified Rad52 and RPA but have thus far been unable to find
the conditions to detect such an interaction in the absence of DNA.
However, it remains quite possible that the interaction between Rad52
and RPA occurs only when these factors are bound to DNA. Consistent
with this premise, it has been demonstrated that Rad52 effectively
anneals DNA strands coated with ScRPA (8, 14) but not with heterologous ssDNA-binding proteins (8), implying a direct interaction between Rad52
and RPA as the likely reason for this observed specificity. We have
demonstrated that the rad52
409-412 mutant is perfectly capable of
mediating ssDNA annealing with an ScRPA-coated template. This result
strongly suggests that the mutant protein also retains the ability to
interact with RPA (14). Given this consideration, our data provide
evidence that the lack of recombination mediator function in
rad52
409-412 is specifically due to its inability to form a complex
with Rad51 protein.
409-412 mutant
strain can be complemented by Rad51 overproduction. It seems possible that a substantial increase in the intracellular pool of Rad51 may
accelerate the assembly of the presynaptic Rad51 filament, thus
rendering this process less prone to the competitive effect of RPA even
when the Rad52 mediator function has been disabled, as in the case of
the rad52
409-412 mutant. However, a more attractive explanation is that the elevated Rad51 levels facilitate complex formation between Rad51 and other mediator proteins. This could conceivably lead to more effective loading of Rad51 onto ssDNA via the
other recombination mediators. In fact, our observation that Rad51
shows only a weak interaction with the Rad55-Rad57 complex4 (11) is congruent
with the latter view. Mutants of the RAD59 gene show some
deficiency in Rad51-dependent recombination events (34,
35). It remains to be seen whether Rad59 also functions as a mediator
in Rad51-catalyzed homologous DNA pairing and strand exchange and, if
so, whether the mediator activity of Rad59 will require complex
formation with Rad51 that is enhanced by increased intracellular Rad51 levels.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Adriana Antunez de Mayolo for helping out with the gamma-ray experiment.
| |
FOOTNOTES |
|---|
* This work was supported by United States Public Health Service Grants RO1 ES07061, RO1 GM57814, RO1 GM50237, and T32 CA86800, by Human Frontier Research Project Grant HFSP RG0178/2000-M, and by The Danish Technical Research Council, by the Alfred Benzon Foundation, and by NATO Science Fellowship.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence may be addressed. Tel.: 210-567-7215; Fax:
210-567-7277; E-mail: krejci@uthscsa.edu.
§ Present address: Dept. of Biochemistry, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322.
** To whom correspondence may also be addressed. Tel.: 45-4525-2701; Fax: 45-4588-4148; E-mail: um@buiocentrum.dtu.dk.
Published, JBC Papers in Press, August 8, 2002, DOI 10.1074/jbc.M206511200
2 L. Krejci and P. Song, unpublished observation.
3 R. Rothstein and U. H. Mortensen, unpublished observation.
4 L. Krejci and P. Song, unpublished observation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ssDNA, single-stranded DNA; RPA, replication protein A; ScRPA, Saccharomyces cerevisiae RPA; DTT, dithiothreitol; GST, glutathione S-transferase; Oligo, oligonucleotide; aa, amino acid; MOPS, 4-morpholinepropanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Pierce, A. J., Stark, J. M., Araujo, F. D., Moynahan, M. E., Berwick, M., and Jasin, M. (2001) Trends Cell Biol. 11, S52-59[Medline] [Order article via Infotrieve] |
| 2. | Sung, P., Trujillo, K. M., and Van Komen, S. (2000) Mutat. Res. 451, 257-275[Medline] [Order article via Infotrieve] |
| 3. |
Paques, F.,
and Haber, J. E.
(1999)
Microbiol. Mol. Biol. Rev.
63,
349-404 |
| 4. | Cox, M. M. (2001) Annu. Rev. Genet. 35, 53-82[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Sung, P.
(1994)
Science
265,
1241-1243 |
| 6. | Bianco, P. R., Tracy, R. B., and Kowalczykowski, S. C. (1998) Front. Biosci. 3, D570-603[Medline] [Order article via Infotrieve] |
| 7. | Roca, A. I., and Cox, M. M. (1997) Prog. Nucleic Acids Res. Mol. Biol. 56, 129-223[Medline] [Order article via Infotrieve] |
| 8. |
Sugiyama, T.,
New, J. H.,
and Kowalczykowski, S. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6049-6054 |
| 9. |
Sigurdsson, S.,
Trujillo, K.,
Song, B.,
Stratton, S.,
and Sung, P.
(2001)
J. Biol. Chem.
276,
8798-8806 |
| 10. | Beernink, H. T., and Morrical, S. W. (1999) Trends Biochem. Sci. 24, 385-389[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Sung, P.
(1997)
Genes Dev.
11,
1111-1121 |
| 12. |
Sung, P.
(1997)
J. Biol. Chem.
272,
28194-28197 |
| 13. | New, J. H., Sugiyama, T., Zaitseva, E., and Kowalczykowski, S. C. (1998) Nature 391, 407-410[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Shinohara, A., Shinohara, M., Ohta, T., Matsuda, S., and Ogawa, T. (1998) Genes Cells 3, 145-156[Abstract] |
| 15. |
Mortensen, U. H.,
Bendixen, C.,
Sunjevaric, I.,
and Rothstein, R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10729-10734 |
| 16. | Sherman, F. (1991) in Guide to Yeast Genetics and Molecular Biology (Guthrie, C. , and Fink, G. R., eds) , pp. 3-21, Academic Press, San Diego, CA |
| 17. | Thomas, B. J., and Rothstein, R. (1989) Cell 56, 619-630[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Fan, H. Y., Cheng, K. K., and Klein, H. L. (1996) Genetics 142, 749-759[Abstract] |
| 19. | Zou, H., and Rothstein, R. (1997) Cell 90, 87-96[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Sherman, F., Fink, G. R., and Hicks, J. B. (1986) Methods in Yeast Genetics , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 21. |
Erdeniz, N.,
Mortensen, U. H.,
and Rothstein, R.
(1997)
Genome Res.
7,
1174-1183 |
| 22. |
Trujillo, K. M.,
and Sung, P.
(2001)
J. Biol. Chem.
276,
35458-35464 |
| 23. |
Song, B.,
and Sung, P.
(2000)
J. Biol. Chem.
275,
15895-15904 |
| 24. | Petukhova, G., Stratton, S., and Sung, P. (1998) Nature 393, 91-94[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Jiang, H.,
Xie, Y.,
Houston, P.,
Stemke-Hale, K.,
Mortensen, U. H.,
Rothstein, R.,
and Kodadek, T.
(1996)
J. Biol. Chem.
271,
33181-33186 |
| 26. |
Smith, J.,
and Rothstein, R.
(1999)
Genetics
151,
447-458 |
| 27. |
Lisby, M.,
Rothstein, R.,
and Mortensen, U. H.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8276-8282 |
| 28. |
Adzuma, K.,
Ogawa, T.,
and Ogawa, H.
(1984)
Mol. Cell. Biol.
4,
2735-2744 |
| 29. |
Milne, G. T.,
and Weaver, D. T.
(1993)
Genes Dev.
7,
1755-1765 |
| 30. |
Passy, S. I., Yu, X., Li, Z.,
Radding, C. M.,
and Egelman, E. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4279-4284 |
| 31. | Kaytor, M. D., and Livingston, D. M. (1996) Curr. Genet. 29, 203-210[Medline] [Order article via Infotrieve] |
| 32. | Boundy-Mills, K. L., and Livingston, D. M. (1993) Genetics 133, 39-49[Abstract] |
| 33. |
Hays, S. L.,
Firmenich, A. A.,
Massey, P.,
Banerjee, R.,
and Berg, P.
(1998)
Mol. Cell. Biol.
18,
4400-4406 |
| 34. |
Bai, Y.,
and Symington, L. S.
(1996)
Genes Dev.
10,
2025-2037 |
| 35. |
Bai, Y.,
Davis, A. P.,
and Symington, L. S.
(1999)
Genetics
153,
1117-1130 |
| 36. |
Asleson, E. N.,
Okagaki, R. J.,
and Livingston, D. M.
(1999)
Genetics
153,
681-692 |
This article has been cited by other articles:
![]() |
C. Seong, M. G. Sehorn, I. Plate, I. Shi, B. Song, P. Chi, U. Mortensen, P. Sung, and L. Krejci Molecular Anatomy of the Recombination Mediator Function of Saccharomyces cerevisiae Rad52 J. Biol. Chem., May 2, 2008; 283(18): 12166 - 12174. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Busygina, M. G. Sehorn, I. Y. Shi, H. Tsubouchi, G. S. Roeder, and P. Sung Hed1 regulates Rad51-mediated recombination via a novel mechanism Genes & Dev., March 15, 2008; 22(6): 786 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Strom, C. Karlsson, H. B. Lindroos, S. Wedahl, Y. Katou, K. Shirahige, and C. Sjogren Postreplicative Formation of Cohesion Is Required for Repair and Induced by a Single DNA Break Science, July 13, 2007; 317(5835): 242 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Storici, J. R. Snipe, G. K. Chan, D. A. Gordenin, and M. A. Resnick Conservative Repair of a Chromosomal Double-Strand Break by Single-Strand DNA through Two Steps of Annealing Mol. Cell. Biol., October 15, 2006; 26(20): 7645 - 7657. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Thorpe, V. A. Marrero, M. H. Savitzky, I. Sunjevaric, T. C. Freeman, and R. Rothstein Cells Expressing Murine RAD52 Splice Variants Favor Sister Chromatid Repair Mol. Cell. Biol., May 15, 2006; 26(10): 3752 - 3763. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. de Mayolo, M. Lisby, N. Erdeniz, T. Thybo, U. H. Mortensen, and R. Rothstein Multiple start codons and phosphorylation result in discrete Rad52 protein species. Nucleic Acids Res., January 1, 2006; 34(9): 2587 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
|